Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sarasini

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of General Virology|April 1, 1988
The outer capsid glycoprotein VP7 of simian rotavirus SA11 contains two distinct neutralization epitopesG Gerna, A Sarasini, A di Matteo, et al.
Journal of Medical Virology|July 1, 1990
Nosocomial outbreak of neonatal gastroenteritis caused by a new serotype 4, subtype 4B human rotavirusG Gerna, J Forster, M Parea, et al.
The Journal of Infectious Diseases|September 9, 1999
Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetusesM Grazia Revello, M Zavattoni, A Sarasini, et al.
The New Microbiologica|November 11, 1999
Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different agesE Cattaneo, M Zavattoni, F Baldanti, et al.
Journal of Clinical Microbiology|June 1, 1990
Serotype 3 human rotavirus strains with subgroup I specificityG Gerna, A Sarasini, A Di Matteo, et al.
Journal of Virology|February 1, 1995
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolateF Baldanti, E Silini, A Sarasini, et al.
ESMO Open|April 15, 2022
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort studyA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|August 27, 2022
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concernA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-upA Lasagna, D Lilleri, F Agustoni, et al.
ESMO Open|September 20, 2021
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort studyA Lasagna, F Agustoni, E Percivalle, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of General Virology|April 1, 1988
The outer capsid glycoprotein VP7 of simian rotavirus SA11 contains two distinct neutralization epitopesG Gerna, A Sarasini, A di Matteo, et al.
Journal of Medical Virology|July 1, 1990
Nosocomial outbreak of neonatal gastroenteritis caused by a new serotype 4, subtype 4B human rotavirusG Gerna, J Forster, M Parea, et al.
The Journal of Infectious Diseases|September 9, 1999
Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetusesM Grazia Revello, M Zavattoni, A Sarasini, et al.
The New Microbiologica|November 11, 1999
Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different agesE Cattaneo, M Zavattoni, F Baldanti, et al.
Journal of Clinical Microbiology|June 1, 1990
Serotype 3 human rotavirus strains with subgroup I specificityG Gerna, A Sarasini, A Di Matteo, et al.
Journal of Virology|February 1, 1995
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolateF Baldanti, E Silini, A Sarasini, et al.
ESMO Open|April 15, 2022
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort studyA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|August 27, 2022
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concernA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-upA Lasagna, D Lilleri, F Agustoni, et al.
ESMO Open|September 20, 2021
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort studyA Lasagna, F Agustoni, E Percivalle, et al.
Pageof 6